Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online August 17, 2007
Diabetes 56:2715-2721, 2007
DOI: 10.2337/db06-1294
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1294v1
db06-1294v2
56/11/2715    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wadham, C.
Right arrow Articles by Xia, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wadham, C.
Right arrow Articles by Xia, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

High Glucose Attenuates Protein S-Nitrosylation in Endothelial Cells

Role of Oxidative Stress

Carol Wadham1, Angela Parker1, Lijun Wang2, and Pu Xia1,2

1 Signal Transduction Laboratory, Division of Human Immunology, Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, Australia
2 Signal Transduction Laboratory, Centenary Institute, and Faculty of Medicine, the University of Sydney, Sydney, Australia

Address correspondence and reprint requests to Pu Xia, MD, Signal Transduction Laboratory, Centenary Institute, Locked Bag 6, Newtown, NSW 2042, Australia. E-mail: p.xia{at}centenary.org.au

Abbreviations: 4-OHCA, {alpha}-cyano-4-hydroxycinnamic acid; CCCP, carbonyl cyanide m-chlorophenyl hydrazone; DPI, diphenyleneiodonium; eNOS, endothelial nitric oxide synthase; FITC, fluorescein isothiocyanate; GSNO, nitrosylated glutathione; GSH, reduced glutathione; HEN, HEPES, EDTA, neocuproine; HUVEC, human umbilical vein endothelial cell; IKKß, inhibitory {kappa}B kinase-ß; mETC, mitochondrial electron transport chain; NF-{kappa}B, nuclear factor-{kappa}B; NOS, nitric oxide synthase; NOX, NAD(P)H oxidase; oxLDL, oxidized LDL; ROS, reactive oxygen species; TNF-{alpha}, tumor necrosis factor-{alpha}; TTFA, thenoyltrifluoroacetone

OBJECTIVE—Hyperglycemia-induced endothelial dysfunction, via a defect of nitric oxide (NO) bioactivity and overproduction of superoxide, is regarded as one of the most significant events contributing to the vascular lesions associated with diabetes. However, the mechanisms underlying such hyperglycemic injury remain undefined. We hypothesized that alterations in cellular protein S-nitrosylation may contribute to hyperglycemia-induced endothelial dysfunction.

RESEARCH DESIGN AND METHODS—We exposed endothelial cells to high glucose in the presence and absence of reactive oxygen species inhibitors and used the biotin switch assay to analyze the alteration in the global pattern of protein S-nitrosylation compared with cells cultured under normal glucose conditions. We identified endogenous S-nitrosylated proteins by mass spectrometry and/or immunoblotting with specific antibodies.

RESULTS—High-glucose treatment induced a significant reduction of endogenous S-nitrosylated proteins that include endothelial NO synthase, ß-actin, vinculin, diacylglycerol kinase-{alpha}, GRP78, extracellular signal–regulated kinase 1, and transcription factor nuclear factor-{kappa}B (NF-{kappa}B). Interestingly, these changes were completely reversed by inhibition of superoxide production, suggesting a key role for oxidative stress in the regulation of S-nitrosylation under hyperglycemic conditions. In addition, we found that in parallel with the restoration of decreased S-nitrosylation of NF-{kappa}B, high glucose–induced NF-{kappa}B activation was blocked by the superoxide inhibitors.

CONCLUSIONS—The alterations in protein S-nitrosylation may underlie the adverse effect of hyperglycemia on the vasculature, such as endothelial dysfunction and the development of diabetic vascular complications.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.